Menu
Recruiting NCT05769699

Serum Biomarkers in Parkinson's Disease at Different Stages

No phase Interventional Parkinson Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: blood sample.
Who it may be relevant to
Registry conditions: Parkinson Disease. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers

Interventions

  • Procedure blood sample
    blood sample

Primary outcome measures

  • Determine clinical characteristics of parkinsonian patients in various stages of disease [Time frame: 3 years]
  • Determine clinical characteristics of parkinsonian patients in various stages of disease [Time frame: 3 years]
  • Determine biooogical characteristics of parkinsonian patients in various stages of disease [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

  • Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
  • Age: 18-80 years;
  • Signature of informed consent to participate in this study

Exclusion criteria.

  • Women pregnant
  • Inflammatory or autoimmune diseases

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

Italy · 1 center
  • Flavia Torlizzi — Roma

Identifiers

NCT: NCT05769699 · 4687

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗